medline.ch Respirationstrakt Neoplasie

	AI-Assisted Volumetric Comparison of Parenchyma-Sparing Effect in Robotic Segmentectomy vs Lobectomy. JSLS Sayan M, Aytekin Celik I, Fattahov M, Artiran B, Temirkaynak FO, Celik A. PMID: 42859444 [PubMed - indexed for MEDLINE]
	Tissue-specific variability in protein expression of cytochrome P450 and glutathione S-transferase isoenzymes in non-small cell lung carcinoma. Arh Hig Rada Toksikol K, O, Çelik S, Demira, B, , Ada AO. PMID: 42859408 [PubMed - indexed for MEDLINE]
	Early postoperative body-composition trajectories and exploratory ratio-defined phenotypes after laryngectomy for laryngeal cancer: a prospective cohort study. Support Care Cancer Chen F, Gui Y, Zheng Y, Wang L, Wu Z, Huang Q. PMID: 42859280 [PubMed - indexed for MEDLINE]
	Prognostic implications of asymptomatic COVID-19 infection in non-small-cell lung cancer patients receiving active anticancer treatment: an observational study with prospective survival follow-up. Cancer Treat Res Commun Wong SY, Chan SY, Chan SK, Chau TC, Tam YH, Chan JFW, Ip CY, Choi HC, Ng SC, Yuen KK, Lee VH. PMID: 42858728 [PubMed - as supplied by publisher]
	Daidzein derivatives as potential inhibitors of mutant EGFR in non-small cell lung cancer: A computational study supported by molecular docking, DFT, molecular dynamics simulations, and MM/PBSA techniques. Comput Methods Programs Biomed Munir F, Hussain K, Zhao G, Zhang J. PMID: 42858544 [PubMed - as supplied by publisher]
	Efficacy and Safety of CyberKnife-Based SBRT and Linear Accelerator-Based IMRT/VMAT for Thoracic Radiotherapy in Non-Small Cell Lung Cancer: A Propensity Score-Matched Real-World Analysis. Technol Cancer Res Treat Sun S, Duan Y, Yang G, Xiao H, Chen X, Wang Z, Ma J, Su K, Chen C, Tong X, Xiong Y, Yang X, Li M. PMID: 42857984 [PubMed - indexed for MEDLINE]
	Comparative Efficacy of First-Line versus Further-Line Icotinib Therapy in Advanced Lung Adenocarcinoma: A Real-World Cohort Study. Onco Targets Ther Zhang X, Wang J, Chen J. PMID: 42857742 [PubMed]
	Natural metabolites targeting macrophage polarization for non-small cell lung cancer therapy: a review of mechanisms and applications based on chemical classification. Front Pharmacol Zhang Y, Liu L, Dai X, Yan H, Lei X, Yang H. PMID: 42857493 [PubMed]
	PI3K/AKT/mTOR signaling at the immune checkpoint interface in lung cancer: molecular mechanisms, Tumor-Immune remodeling, therapeutic resistance, and emerging treatment strategies. Front Cell Dev Biol Jin H, Yang F, Zong S, Sun W. PMID: 42857335 [PubMed]
	Preoperative risk stratification for pulmonary complications after neoadjuvant therapy and esophagectomy in locally advanced esophageal squamous cell carcinoma: a retrospective cohort study. Front Oncol Lv H, Wang M, Zhu M, Lu T, Ma Y, Han R. PMID: 42857285 [PubMed]
	An explainable nomogram incorporating systemic inflammatory indicators and radiation esophagitis for risk assessment of radiation pneumonitis in lung cancer. Front Immunol Li J, Li C, Liu J, Wang C, Zhao Y, Ge A, Dong Y, Yang X. PMID: 42857233 [PubMed - indexed for MEDLINE]
	Not all major pathological responses are equal: prognostic heterogeneity and risk stratification after neoadjuvant chemoimmunotherapy in resectable NSCLC. Front Immunol Lin J, Xu H, Tang J, He C, Li P, Lin X, Wu J, Huang Z, Huang C, Xie Z, Wu H. PMID: 42857111 [PubMed - indexed for MEDLINE]
	Efficacy and safety of induction benmelstobart plus anlotinib and chemotherapy followed by concurrent chemoradiotherapy and benmelstobart consolidation versus concurrent chemoradiotherapy followed by benmelstobart consolidation in patients with unresectable stage III NSCLC: a randomized, controlled, multicenter phase II trial protocol (BEAM-LUNG). Front Immunol Song Z, Ma S, Zhang X, Liu X. PMID: 42857095 [PubMed - indexed for MEDLINE]
	Adoptive cell therapy in lung cancer: progress, challenges, and prospects. Chin Med J Pulm Crit Care Med Li J, Tong C, Chen Y, Zhu B. PMID: 42856948 [PubMed]
	Development and internal validation of a machine-learning model for 3-year mortality after lung cancer resection: an online risk calculator and nomogram. Front Med (Lausanne) Liu C, Wu Y, Wang J, Lei K, Xing Y, Kang M, Gao Q, Shen Y. PMID: 42856825 [PubMed]
	Application of Multimodal Respiratory Training Combined With Resistance Exercise in Promoting Postoperative Recovery After Thoracoscopic Lung Cancer Resection. Asia Pac J Clin Oncol Wu J, Liu J, Luo B, Yuan L, Yuan Y, Wang W, Wen B, Wang X. PMID: 42855870 [PubMed - as supplied by publisher]
	Prognostic value of the Global Leadership Initiative on Malnutrition for clinical outcomes in outpatients with colorectal and/or lung cancer: an observational prospective study. Nutrition Estanislau AMDC, Maia FCP, Lima AI, Silva LC, Generoso SV, Maurício SF, Correia MITD. PMID: 42854379 [PubMed - as supplied by publisher]
	Single-center experience with Romiplostim N01 for the management of severe persistent cancer therapy-induced thrombocytopenia in lung cancer: Insights and outcomes. Medicine (Baltimore) Wang C, Wu C, Wang G, Wang K, Fei S, Zong Y, Dong X, Zhang S, Zhou R. PMID: 42854051 [PubMed - indexed for MEDLINE]
	Direction of discordance between PET/CT, EBUS-TBNA, and multidisciplinary tumor board nodal assignment in non-small cell lung cancer: A retrospective observational study. Medicine (Baltimore) Terzi OE, Demirdö, Acet Öztürk NA, Aydin Güçlü Ö, Ursava. PMID: 42854031 [PubMed - indexed for MEDLINE]
	Dual-scope method for hemostasis during transbronchial lung cryobiopsy: A two-patient case report. Medicine (Baltimore) Hanawa R, Okamori S, Suzuki M, Asakura K, Kohno M, Nakachi I. PMID: 42854028 [PubMed - indexed for MEDLINE]

Artikel 1 - 20 / 163657

Seite 1 von 8183



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung